Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Stopped The study was terminated due to low accrual and insufficient efficacy seen in first few participants treated.

Conditions

• Pancreatic Acinar Cell Carcinoma

Interventions

• DRUG: Olaparib
• DIAGNOSTIC_TEST: ECG
• DIAGNOSTIC_TEST: CT CAP
• PROCEDURE: Tumor Biopsy

Sponsor

National Cancer Institute (NCI)